autologous blood and marrow transplantation - Blog Science ...

Hoeker and Gökbuget
tical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first
remission. Bone Marrow Transplant 22:243, 1998.
17. de Witte T, Oberg G, Or R, Gratwohl A, Niederwieser D, Van Beizen A, Hermans J, Runde
V, Meloni G, Morgan G, Apperley J, Vernant J, Kolb H, Vossen J, Ljungman P, Beelen
D, Ferrant A, Arnold R, Cahn J, Bacigalupo A, Fibbe W, Gorin N: Autologous bone mar­
row transplantation (ABMT) for patients with myelodysplastic syndromes (MDS) or
leukaemia following MDS (sAML): A survey for the Working Parties on Chronic and
Acute Leukaemia of the EBMTG. Br J Haematol 87 (Suppl 1):29,1994.
18. Forman S J, Chao N, Niland JC, Levitt L, Champlin R, Gajewski J, Lee J, Schiller G, Nantel
S, Barnett M, Levine A, Saez R, Phillips G, Blume KG: Intensive chemotherapy or bone
marrow transplantation for adult ALL in first complete remission. Blood 86 (Suppl):616a,
1995.
19. Mrsic M, Nemet D, Labar B, et al.: Chemotherapy versus allogeneic bone marrow trans­
plantation in adults with acute lymphoblastic leukemia. Transplant Proc 25:1268,1993.
20. Sebban C, Lepage E, Witz F, Dufour P, Gratecos N, Huguet F, Braustet A, Pignon B,
Troussard X, Cahn JY, Cordonnier C, Fiere DF: Prognostic value of early response to
chemotherapy in adult acute lymphoblastic leukemia: A study of 437 patients included
in the LALA87 trial. Br J Haematol 87 (Suppl 1):20, 1994.
21. Dicke KA, Hoelzer DF, Gorin NC, Lowenberg B, Gale RP: The role of bone marrow trans­
plantation in adult acute lymphocytic leukemia. Ann Oncol 4 (Suppl 1):81,1993.
22. Hoelzer D, Thiel E, Loeffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich
H: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia
in adults. Blood 71:123, 1988.
23. Campana D, Pui C-H: Detection of minimal residual disease in acute leukemia:
Methodological advances and clinical significance. Blood 85:1416,1995.
24. Brisco MJ, Condon J, Highes E, Neoh S-H, Sykes PJ, Seshadri R, Toogood I, Waters K,
Tauro G, Ekert H, Morley AA: Outcome prediction in childhood acute lymphoblastic
leukaemia by molecular quantification of residual disease at the end of induction. Lancet
343:196, 1994.
25. Brisco MJ, Hughes E, Neoh SH, Sykes PJ, Bradstock K, Enno A, Szer J, McCaul K,
Morley AA: Relationship between minimal residual disease and outcome in adult acute
lymphoblastic leukemia. Blood 87:5251, 1996.
26. van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral
L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering E, Ludwig WD,
Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop
WC, Riehm H, Bartram CR: Prognostic value of minimal residual disease in acute lym­
phoblastic leukemia in childhood. Lancet 352:1731,1998.
27. Cave H, Van der Werff Ten Bosch J, Suciu S, Guidai C, Waterkeyn C, Otten J, Bakkus
M, Thielemans K, Grandchamp B, Vilmer E, for the European Organization for Research
and Treatment of Cancer-Childhood Leukemia Cooperative Group: Clinical significance
of minimal residual disease in childhood acute lymphoblastic leukemia. N Engl J Med
339:591, 1998.
71